Category: Zacks Small Cap Research
By John Vandermosten, CFA NASDAQ:LEXX READ THE FULL LEXX RESEARCH REPORT We are initiating coverage of Lexaria Bioscience Corp. (NASDAQ:LEXX) with a valuation of $15.00 per share. This present value is based on cash flows related to probability adjus ...
By David Bautz, PhD NASDAQ:EDSA READ THE FULL EDSA RESEARCH REPORT Business Update Positive Results for Phase 2 Study of EB05 in Critically Ill COVID-19 Patients On September 20, 2021, Edesa Biotech, Inc. (NASDAQ:EDSA) announced positive results from ...
By John Vandermosten, CFA NASDAQ:TENX READ THE FULL TENX RESEARCH REPORT Second Quarter 2021 Financial and Operational Review Tenax Therapeutics, Inc. (NASDAQ:TENX) reported second quarter 2021 results via the issuance of a press release and the fili ...
By John Vandermosten, CFA NASDAQ:MDXG READ THE FULL MDXG RESEARCH REPORT Topline Results from Phase IIb KOA and Phase III PF On September 13, 2021, MiMedx Group, Inc. (NASDAQ:MDXG) reported results from its Phase IIb Knee Osteoarthritis (KOA) study a ...
By John Vandermosten, CFA NASDAQ:NOVN READ THE FULL NOVN RESEARCH REPORT September Update On September 9, 2021, Novan (NASDAQ:NOVN) hosted a corporate update conference call and webcast. The call was led by Novan President and CEO, Paula Brown Staf ...
By John Vandermosten, CFA NASDAQ:TLSA READ THE FULL TLSA RESEARCH REPORT Tiziana Update Call with Analysts and Investors Precision BioSciences On September 8, 2021 following the market close, Tiziana Life Sciences (NASDAQ:TLSA) hosted a web conferenc ...
By David Bautz, PhD NASDAQ:BTAI READ THE FULL BTAI RESEARCH REPORT Business Update Encouraging Data for BXCL701 in Heavily Pretreated mCRPC Population On September 15, 2021, BioXcel Therapeutics, Inc. (BTAI) announced that data from the ongoing Phase ...
By T. Moore, CFA NASDAQ:YTRA READ THE FULL YTRA RESEARCH REPORT Business News Update We were pleasantly surprised by the news that Yatra Online, Inc. (NASDAQ:YTRA) is considering whether to do additional listing of its Indian subsidiary on stock exch ...
By John Vandermosten, CFA NASDAQ:ALZN | NASDAQ:BIIB Alzamend Neuro, Inc. (NASDAQ:ALZN) is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative and psychiatric disorders. The Tam ...
By Steven Ralston, CFA OTC:BLSTF | ASX:BSX READ THE FULL BLSTF RESEARCH REPORT Blackstone Minerals (OTC:BLSTF) (ASX:BSX) is advancing both upstream and downstream nickel projects in northern Vietnam. The upstream Ta Khoa Project is developing a serie ...